Financial toxicity and cancer treatments: Help from biosimilars – The explanatory case of bevacizumab
Jacopo Giuliani, Francesco Fiorica, Vito Albanese, Andrea Bonetti
Topics & Concepts
BiosimilarBevacizumabMedicineOncologyColorectal cancerInternal medicineCancerMetastatic breast cancerIntensive care medicineBreast cancerChemotherapyBiosimilars and Bioanalytical MethodsHealth Systems, Economic Evaluations, Quality of LifeEconomic and Financial Impacts of Cancer